Topology File Tutorial
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Real-Time Pymol Visualization for Rosetta and Pyrosetta
Real-Time PyMOL Visualization for Rosetta and PyRosetta Evan H. Baugh1, Sergey Lyskov1, Brian D. Weitzner1, Jeffrey J. Gray1,2* 1 Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland, United States of America, 2 Program in Molecular Biophysics, The Johns Hopkins University, Baltimore, Maryland, United States of America Abstract Computational structure prediction and design of proteins and protein-protein complexes have long been inaccessible to those not directly involved in the field. A key missing component has been the ability to visualize the progress of calculations to better understand them. Rosetta is one simulation suite that would benefit from a robust real-time visualization solution. Several tools exist for the sole purpose of visualizing biomolecules; one of the most popular tools, PyMOL (Schro¨dinger), is a powerful, highly extensible, user friendly, and attractive package. Integrating Rosetta and PyMOL directly has many technical and logistical obstacles inhibiting usage. To circumvent these issues, we developed a novel solution based on transmitting biomolecular structure and energy information via UDP sockets. Rosetta and PyMOL run as separate processes, thereby avoiding many technical obstacles while visualizing information on-demand in real-time. When Rosetta detects changes in the structure of a protein, new coordinates are sent over a UDP network socket to a PyMOL instance running a UDP socket listener. PyMOL then interprets and displays the molecule. This implementation also allows remote execution of Rosetta. When combined with PyRosetta, this visualization solution provides an interactive environment for protein structure prediction and design. Citation: Baugh EH, Lyskov S, Weitzner BD, Gray JJ (2011) Real-Time PyMOL Visualization for Rosetta and PyRosetta. -
An Explicit-Solvent Conformation Search Method Using Open Software
An explicit-solvent conformation search method using open software Kari Gaalswyk and Christopher N. Rowley Department of Chemistry, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada ABSTRACT Computer modeling is a popular tool to identify the most-probable conformers of a molecule. Although the solvent can have a large effect on the stability of a conformation, many popular conformational search methods are only capable of describing molecules in the gas phase or with an implicit solvent model. We have developed a work-flow for performing a conformation search on explicitly-solvated molecules using open source software. This method uses replica exchange molecular dynamics (REMD) to sample the conformational states of the molecule efficiently. Cluster analysis is used to identify the most probable conformations from the simulated trajectory. This work-flow was tested on drug molecules a-amanitin and cabergoline to illustrate its capabilities and effectiveness. The preferred conformations of these molecules in gas phase, implicit solvent, and explicit solvent are significantly different. Subjects Biophysics, Pharmacology, Computational Science Keywords Conformation search, Explicit solvent, Cluster analysis, Replica exchange molecular dynamics INTRODUCTION Many molecules can exist in multiple conformational isomers. Conformational isomers have the same chemical bonds, but differ in their 3D geometry because they hold different torsional angles (Crippen & Havel, 1988). The conformation of a molecule can affect Submitted 5 April 2016 chemical reactivity, molecular binding, and biological activity (Struthers, Rivier & Accepted 6May2016 Published 31 May 2016 Hagler, 1985; Copeland, 2011). Conformations differ in stability because they experience different steric, electrostatic, and solute-solvent interactions. The probability, p,ofa Corresponding author Christopher N. -
Python Tools in Computational Chemistry (And Biology)
Python Tools in Computational Chemistry (and Biology) Andrew Dalke Dalke Scientific, AB Göteborg, Sweden EuroSciPy, 26-27 July, 2008 “Why does ‘import numpy’ take 0.4 seconds? Does it need to import 228 libraries?” - My first Numpy-discussion post (paraphrased) Your use case isn't so typical and so suffers on the import time end of the balance. - Response from Robert Kern (Others did complain. Import time down to 0.28s.) 52,000 structures PDB doubles every 2½ years HEADER PHOTORECEPTOR 23-MAY-90 1BRD 1BRD 2 COMPND BACTERIORHODOPSIN 1BRD 3 SOURCE (HALOBACTERIUM $HALOBIUM) 1BRD 4 EXPDTA ELECTRON DIFFRACTION 1BRD 5 AUTHOR R.HENDERSON,J.M.BALDWIN,T.A.CESKA,F.ZEMLIN,E.BECKMANN, 1BRD 6 AUTHOR 2 K.H.DOWNING 1BRD 7 REVDAT 3 15-JAN-93 1BRDB 1 SEQRES 1BRDB 1 REVDAT 2 15-JUL-91 1BRDA 1 REMARK 1BRDA 1 .. ATOM 54 N PRO 8 20.397 -15.569 -13.739 1.00 20.00 1BRD 136 ATOM 55 CA PRO 8 21.592 -15.444 -12.900 1.00 20.00 1BRD 137 ATOM 56 C PRO 8 21.359 -15.206 -11.424 1.00 20.00 1BRD 138 ATOM 57 O PRO 8 21.904 -15.930 -10.563 1.00 20.00 1BRD 139 ATOM 58 CB PRO 8 22.367 -14.319 -13.591 1.00 20.00 1BRD 140 ATOM 59 CG PRO 8 22.089 -14.564 -15.053 1.00 20.00 1BRD 141 ATOM 60 CD PRO 8 20.647 -15.054 -15.103 1.00 20.00 1BRD 142 ATOM 61 N GLU 9 20.562 -14.211 -11.095 1.00 20.00 1BRD 143 ATOM 62 CA GLU 9 20.192 -13.808 -9.737 1.00 20.00 1BRD 144 ATOM 63 C GLU 9 19.567 -14.935 -8.932 1.00 20.00 1BRD 145 ATOM 64 O GLU 9 19.815 -15.104 -7.724 1.00 20.00 1BRD 146 ATOM 65 CB GLU 9 19.248 -12.591 -9.820 1.00 99.00 1 1BRD 147 ATOM 66 CG GLU 9 19.902 -11.351 -10.387 1.00 99.00 1 1BRD 148 ATOM 67 CD GLU 9 19.243 -10.169 -10.980 1.00 99.00 1 1BRD 149 ATOM 68 OE1 GLU 9 18.323 -10.191 -11.782 1.00 99.00 1 1BRD 150 ATOM 69 OE2 GLU 9 19.760 -9.089 -10.597 1.00 99.00 1 1BRD 151 ATOM 70 N TRP 10 18.764 -15.737 -9.597 1.00 20.00 1BRD 152 ATOM 71 CA TRP 10 18.034 -16.884 -9.090 1.00 20.00 1BRD 153 ATOM 72 C TRP 10 18.843 -17.908 -8.318 1.00 20.00 1BRD 154 ATOM 73 O TRP 10 18.376 -18.310 -7.230 1.00 20.00 1BRD 155 . -
Chemical Methods for the Characterization of Proteolysis in Cheese During Ripening Plh Mcsweeney, Pf Fox
Chemical methods for the characterization of proteolysis in cheese during ripening Plh Mcsweeney, Pf Fox To cite this version: Plh Mcsweeney, Pf Fox. Chemical methods for the characterization of proteolysis in cheese during ripening. Le Lait, INRA Editions, 1997, 77 (1), pp.41-76. hal-00929515 HAL Id: hal-00929515 https://hal.archives-ouvertes.fr/hal-00929515 Submitted on 1 Jan 1997 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Lait (1997) 77, 41-76 41 © ElseviernNRA Review Chemical methods for the characterization of proteolysis in cheese during ripening PLH McSweeney, PF Fox Department of Food Chemistry, University College, Cork, Ireland Summary - Proteolysis is the principal and most complex biochemical event which occurs during the maturation of most cheese varieties. Proteolysis has been the subject of much study and a range of analytieal techniques has been developed to assess its extent and nature. Methods for assessing pro- teolysis can he c1assified under two broad headings: non-specifie and specifie techniques, both of which are reviewed. Non-specifie techniques include the quantitation of nitrogen soluble in various extrac- tants or precipitants and the Iiberation of reactive groups. -
Computational Chemistry for Chemistry Educators Shawn C
Volume 1, Issue 1 Journal Of Computational Science Education Computational Chemistry for Chemistry Educators Shawn C. Sendlinger Clyde R. Metz North Carolina Central University College of Charleston Department of Chemistry Department of Chemistry and Biochemistry 1801 Fayetteville Street, 66 George Street, Durham, NC 27707 Charleston, SC 29424 919-530-6297 843-953-8097 [email protected] [email protected] ABSTRACT 1. INTRODUCTION In this paper we describe an ongoing project where the goal is to The majority of today’s students are technologically savvy and are develop competence and confidence among chemistry faculty so often more comfortable using computers than the faculty who they are able to utilize computational chemistry as an effective teach them. In order to harness the student’s interest in teaching tool. Advances in hardware and software have made technology and begin to use it as an educational tool, most faculty research-grade tools readily available to the academic community. members require some level of instruction and training. Because Training is required so that faculty can take full advantage of this chemistry research increasingly utilizes computation as an technology, begin to transform the educational landscape, and important tool, our approach to chemistry education should reflect attract more students to the study of science. this. The ability of computer technology to visualize and manipulate objects on an atomic scale can be a powerful tool to increase both student interest in chemistry as well as their level of Categories and Subject Descriptors understanding. Computational Chemistry for Chemistry Educators (CCCE) is a project that seeks to provide faculty the J.2 [Physical Sciences and Engineering]: Chemistry necessary knowledge, experience, and technology access so that they can begin to design and incorporate computational approaches in the courses they teach. -
Designing Peptidomimetics
CORE Metadata, citation and similar papers at core.ac.uk Provided by UPCommons. Portal del coneixement obert de la UPC DESIGNING PEPTIDOMIMETICS Juan J. Perez Dept. of Chemical Engineering ETS d’Enginyeria Industrial Av. Diagonal, 647 08028 Barcelona, Spain 1 Abstract The concept of a peptidomimetic was coined about forty years ago. Since then, an enormous effort and interest has been devoted to mimic the properties of peptides with small molecules or pseudopeptides. The present report aims to review different approaches described in the past to succeed in this goal. Basically, there are two different approaches to design peptidomimetics: a medicinal chemistry approach, where parts of the peptide are successively replaced by non-peptide moieties until getting a non-peptide molecule and a biophysical approach, where a hypothesis of the bioactive form of the peptide is sketched and peptidomimetics are designed based on hanging the appropriate chemical moieties on diverse scaffolds. Although both approaches have been used in the past, the former has been more widely used to design peptidomimetics of secretory peptides, whereas the latter is nowadays getting momentum with the recent interest in designing protein-protein interaction inhibitors. The present report summarizes the relevance of the information gathered from structure-activity studies, together with a short review on the strategies used to design new peptide analogs and surrogates. In a following section there is a short discussion on the characterization of the bioactive conformation of a peptide, to continue describing the process of designing conformationally constrained analogs producing first and second generation peptidomimetics. Finally, there is a section devoted to review the use of organic scaffolds to design peptidomimetics based on the information available on the bioactive conformation of the peptide. -
Preparing and Analyzing Large Molecular Simulations With
Preparing and Analyzing Large Molecular Simulations with VMD John Stone, Senior Research Programmer NIH Center for Macromolecular Modeling and Bioinformatics, University of Illinois at Urbana-Champaign VMD Tutorials Home Page • http://www.ks.uiuc.edu/Training/Tutorials/ – Main VMD tutorial – VMD images and movies tutorial – QwikMD simulation preparation and analysis plugin – Structure check – VMD quantum chemistry visualization tutorial – Visualization and analysis of CPMD data with VMD – Parameterizing small molecules using ffTK Overview • Introduction • Data model • Visualization • Scripting and analytical features • Trajectory analysis and visualization • High fidelity ray tracing • Plugins and user-extensibility • Large system analysis and visualization VMD – “Visual Molecular Dynamics” • 100,000 active users worldwide • Visualization and analysis of: – Molecular dynamics simulations – Lattice cell simulations – Quantum chemistry calculations – Cryo-EM densities, volumetric data • User extensible scripting and plugins • http://www.ks.uiuc.edu/Research/vmd/ Cell-Scale Modeling MD Simulation VMD – “Visual Molecular Dynamics” • Unique capabilities: • Visualization and analysis of: – Trajectories are fundamental to VMD – Molecular dynamics simulations – Support for very large systems, – “Particle” systems and whole cells now reaching billions of particles – Cryo-EM densities, volumetric data – Extensive GPU acceleration – Quantum chemistry calculations – Parallel analysis/visualization with MPI – Sequence information MD Simulations Cell-Scale -
Kepler Gpus and NVIDIA's Life and Material Science
LIFE AND MATERIAL SCIENCES Mark Berger; [email protected] Founded 1993 Invented GPU 1999 – Computer Graphics Visual Computing, Supercomputing, Cloud & Mobile Computing NVIDIA - Core Technologies and Brands GPU Mobile Cloud ® ® GeForce Tegra GRID Quadro® , Tesla® Accelerated Computing Multi-core plus Many-cores GPU Accelerator CPU Optimized for Many Optimized for Parallel Tasks Serial Tasks 3-10X+ Comp Thruput 7X Memory Bandwidth 5x Energy Efficiency How GPU Acceleration Works Application Code Compute-Intensive Functions Rest of Sequential 5% of Code CPU Code GPU CPU + GPUs : Two Year Heart Beat 32 Volta Stacked DRAM 16 Maxwell Unified Virtual Memory 8 Kepler Dynamic Parallelism 4 Fermi 2 FP64 DP GFLOPS GFLOPS per DP Watt 1 Tesla 0.5 CUDA 2008 2010 2012 2014 Kepler Features Make GPU Coding Easier Hyper-Q Dynamic Parallelism Speedup Legacy MPI Apps Less Back-Forth, Simpler Code FERMI 1 Work Queue CPU Fermi GPU CPU Kepler GPU KEPLER 32 Concurrent Work Queues Developer Momentum Continues to Grow 100M 430M CUDA –Capable GPUs CUDA-Capable GPUs 150K 1.6M CUDA Downloads CUDA Downloads 1 50 Supercomputer Supercomputers 60 640 University Courses University Courses 4,000 37,000 Academic Papers Academic Papers 2008 2013 Explosive Growth of GPU Accelerated Apps # of Apps Top Scientific Apps 200 61% Increase Molecular AMBER LAMMPS CHARMM NAMD Dynamics GROMACS DL_POLY 150 Quantum QMCPACK Gaussian 40% Increase Quantum Espresso NWChem Chemistry GAMESS-US VASP CAM-SE 100 Climate & COSMO NIM GEOS-5 Weather WRF Chroma GTS 50 Physics Denovo ENZO GTC MILC ANSYS Mechanical ANSYS Fluent 0 CAE MSC Nastran OpenFOAM 2010 2011 2012 SIMULIA Abaqus LS-DYNA Accelerated, In Development NVIDIA GPU Life Science Focus Molecular Dynamics: All codes are available AMBER, CHARMM, DESMOND, DL_POLY, GROMACS, LAMMPS, NAMD Great multi-GPU performance GPU codes: ACEMD, HOOMD-Blue Focus: scaling to large numbers of GPUs Quantum Chemistry: key codes ported or optimizing Active GPU acceleration projects: VASP, NWChem, Gaussian, GAMESS, ABINIT, Quantum Espresso, BigDFT, CP2K, GPAW, etc. -
Ratio of Phosphate to Amino Acids
National Institute for Health and Care Excellence Final Neonatal parenteral nutrition [D10] Ratio of phosphate to amino acids NICE guideline NG154 Evidence reviews February 2020 Final These evidence reviews were developed by the National Guideline Alliance which is part of the Royal College of Obstetricians and Gynaecologists FINAL Error! No text of specified style in document. Disclaimer The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties. NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive. -
Enzymatic Aminoacylation of Trna with Unnatural Amino Acids
Enzymatic aminoacylation of tRNA with unnatural amino acids Matthew C. T. Hartman, Kristopher Josephson, and Jack W. Szostak* Department of Molecular Biology and Center for Computational and Integrative Biology, Simches Research Center, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114 Edited by Peter G. Schultz, The Scripps Research Institute, La Jolla, CA, and approved January 24, 2006 (received for review October 21, 2005) The biochemical flexibility of the cellular translation apparatus applicable to screening large numbers of unnatural amino acids. offers, in principle, a simple route to the synthesis of drug-like The commonly used ATP-PPi exchange assay, although very modified peptides and novel biopolymers. However, only Ϸ75 sensitive, does not actually measure the formation of the AA- unnatural building blocks are known to be fully compatible with tRNA product (13). A powerful assay developed by Wolfson and enzymatic tRNA acylation and subsequent ribosomal synthesis of Uhlenbeck (14) allows the observation of AA-tRNA synthesis modified peptides. Although the translation system can reject even with unnatural amino acids through the use of tRNA which substrate analogs at several steps along the pathway to peptide is 32P-labeled at the terminal C-p-A phosphodiester linkage (4, synthesis, much of the specificity resides at the level of the 15). Because the assay is based on the separation of AMP and aminoacyl-tRNA synthetase (AARS) enzymes that are responsible esterified AA-AMP by TLC, each amino acid analog must be for charging tRNAs with amino acids. We have developed an AARS tested in a separate assay mixture; moreover, this assay cannot assay based on mass spectrometry that can be used to rapidly generally distinguish between tRNA charged with the desired identify unnatural monomers that can be enzymatically charged unnatural amino acid or with contaminating natural amino acid. -
Trends in Atomistic Simulation Software Usage [1.3]
A LiveCoMS Perpetual Review Trends in atomistic simulation software usage [1.3] Leopold Talirz1,2,3*, Luca M. Ghiringhelli4, Berend Smit1,3 1Laboratory of Molecular Simulation (LSMO), Institut des Sciences et Ingenierie Chimiques, Valais, École Polytechnique Fédérale de Lausanne, CH-1951 Sion, Switzerland; 2Theory and Simulation of Materials (THEOS), Faculté des Sciences et Techniques de l’Ingénieur, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland; 3National Centre for Computational Design and Discovery of Novel Materials (MARVEL), École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland; 4The NOMAD Laboratory at the Fritz Haber Institute of the Max Planck Society and Humboldt University, Berlin, Germany This LiveCoMS document is Abstract Driven by the unprecedented computational power available to scientific research, the maintained online on GitHub at https: use of computers in solid-state physics, chemistry and materials science has been on a continuous //github.com/ltalirz/ rise. This review focuses on the software used for the simulation of matter at the atomic scale. We livecoms-atomistic-software; provide a comprehensive overview of major codes in the field, and analyze how citations to these to provide feedback, suggestions, or help codes in the academic literature have evolved since 2010. An interactive version of the underlying improve it, please visit the data set is available at https://atomistic.software. GitHub repository and participate via the issue tracker. This version dated August *For correspondence: 30, 2021 [email protected] (LT) 1 Introduction Gaussian [2], were already released in the 1970s, followed Scientists today have unprecedented access to computa- by force-field codes, such as GROMOS [3], and periodic tional power. -
Design and Synthesis of Novel Prodrugs to Modulate Gaba Receptors in Cancer Hui Zhang
DESIGN AND SYNTHESIS OF NOVEL PRODRUGS TO MODULATE GABA RECEPTORS IN CANCER HUI ZHANG Thesis submitted in partial fulfilment of the requirements of Edinburgh Napier University for the degree of Doctor of Philosophy March 2017 Declaration It is hereby declared that this thesis and the research work upon which it is based were conducted by the author, Hui Zhang. Hui Zhang Abstract of Thesis GABA (gamma-amino butanoic acid) is the main inhibitory neurotransmitter in the mammalian central nervous system. GABA has been found to play an inhibitory role in some cancers, including colon carcinoma, cholangiocarcinoma, and lung adenocarcinoma. Growing evidence shows that GABAB receptors are involved in tumour development. The expression level of GABAB receptors was found to be upregulated in some human tumours, including the pancreas, and cancer cell lines, suggesting that GABAB receptors may be potential targets for cancer therapy and diagnosis. In this research programme, several diverse series of potential anticancer prodrugs of GABA and GABA receptor-targeting agents have been rationally designed and synthesised for selective activation in the tumour microenvironment. In one approach, a series of oligopeptide conjugate prodrugs have been synthesised as protease-activatable substrates for either the extracellular matrix metalloproteinase MMP-9 or the lysosomal endoprotease legumain; each of which are overexpressed in the tumour environment and are effectors of tumour growth and metastasis. Specifically, a novel fluorogenic, oligopeptide FRET substrate prodrug of legumain HZ101 (Rho-Pro-Ala-Asn~GABA-spacer-AQ) has been characterised and shown to have theranostic potential. Proof of principle has been demonstrated using recombinant human legumain for which HZ101 is an efficient substrate and is latently quenched until cleaved.